EA201890896A1 - SOLID PREPARATION FOR ORAL APPLICATION CONTAINING AMORPHOUS SOLIPHENACIN, AND A METHOD FOR ITS OBTAINING - Google Patents

SOLID PREPARATION FOR ORAL APPLICATION CONTAINING AMORPHOUS SOLIPHENACIN, AND A METHOD FOR ITS OBTAINING

Info

Publication number
EA201890896A1
EA201890896A1 EA201890896A EA201890896A EA201890896A1 EA 201890896 A1 EA201890896 A1 EA 201890896A1 EA 201890896 A EA201890896 A EA 201890896A EA 201890896 A EA201890896 A EA 201890896A EA 201890896 A1 EA201890896 A1 EA 201890896A1
Authority
EA
Eurasian Patent Office
Prior art keywords
soliphenacin
obtaining
solid preparation
containing amorphous
oral application
Prior art date
Application number
EA201890896A
Other languages
Russian (ru)
Inventor
Хо Тэк Им
Тэк Кван Квон
Сын Бин Ён
Йонг Ил Ким
Дже Хён Пак
Джон Су Ву
Original Assignee
Ханми Фарм. Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ханми Фарм. Ко., Лтд. filed Critical Ханми Фарм. Ко., Лтд.
Publication of EA201890896A1 publication Critical patent/EA201890896A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Abstract

Твердый состав для перорального применения содержит аморфный солифенацин или его фармацевтически приемлемую соль; а также стабилизирующее средство, выбранное из группы, состоящей из алкилцеллюлозы, антиоксиданта и любой их комбинации.The solid formulation for oral use contains amorphous solifenacin or a pharmaceutically acceptable salt thereof; and a stabilizing agent selected from the group consisting of alkylcellulose, antioxidant, and any combination thereof.

EA201890896A 2015-11-11 2016-11-02 SOLID PREPARATION FOR ORAL APPLICATION CONTAINING AMORPHOUS SOLIPHENACIN, AND A METHOD FOR ITS OBTAINING EA201890896A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150158108A KR20170055211A (en) 2015-11-11 2015-11-11 Solid formulation for oral administration containing amorphous solifenacin and a process for the preparation thereof
PCT/KR2016/012490 WO2017082577A1 (en) 2015-11-11 2016-11-02 Amorphous solifenacin-containing solid preparation for oral use and preparation method therefor

Publications (1)

Publication Number Publication Date
EA201890896A1 true EA201890896A1 (en) 2018-10-31

Family

ID=58695652

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201890896A EA201890896A1 (en) 2015-11-11 2016-11-02 SOLID PREPARATION FOR ORAL APPLICATION CONTAINING AMORPHOUS SOLIPHENACIN, AND A METHOD FOR ITS OBTAINING

Country Status (7)

Country Link
KR (1) KR20170055211A (en)
CN (1) CN108348617A (en)
BR (1) BR112018009413A2 (en)
EA (1) EA201890896A1 (en)
MX (1) MX2018005848A (en)
PH (1) PH12018500980A1 (en)
WO (1) WO2017082577A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180003340A (en) * 2016-06-30 2018-01-09 한미약품 주식회사 Solid formulation for oral administration containing amorphous solifenacin and a process for the preparation thereof
KR20200078121A (en) 2018-12-21 2020-07-01 한미약품 주식회사 Composite formulation for oral administration comprising Tamsulosin and Solifenacin and a process for the preparation thereof
KR20200121183A (en) 2019-04-15 2020-10-23 한미약품 주식회사 Composite formulation comprising Tamsulosin and Solifenacin and a process for the preparation thereof
KR20210114271A (en) 2020-03-10 2021-09-23 주식회사 종근당 Pharmaceutical composition comprising solifenacin or its pharmaceutically acceptable salts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100137358A1 (en) * 1996-11-05 2010-06-03 Dr. Reddy's Laboratories Ltd. Solifenacin compositions
JP4816828B2 (en) * 2009-03-30 2011-11-16 アステラス製薬株式会社 Solid pharmaceutical composition containing amorphous solifenacin
KR20150092385A (en) * 2014-02-03 2015-08-13 씨제이헬스케어 주식회사 Stable pharmaceutical composition comprising solifenacin, and method for preparing the same
KR20150102852A (en) * 2014-02-28 2015-09-08 대원제약주식회사 Solid dispersion composition with increased stability comprising amorphous solifenacin or pharmaceutically acceptable salts thereof
WO2015170237A1 (en) * 2014-05-05 2015-11-12 Torrent Pharmaceuticals Limited Stable solifenacin composition

Also Published As

Publication number Publication date
WO2017082577A1 (en) 2017-05-18
CN108348617A (en) 2018-07-31
PH12018500980A1 (en) 2019-01-28
KR20170055211A (en) 2017-05-19
BR112018009413A2 (en) 2018-12-04
MX2018005848A (en) 2019-07-18

Similar Documents

Publication Publication Date Title
EA201791256A1 (en) HINAZOLIN DERIVATIVES USED FOR HIV TREATMENT
EA201791692A1 (en) 4H-PIRROLO [3,2-c] PYRIDIN-4-ONE DERIVATIVES
EA201791304A1 (en) IZOHINOLINA DERIVATIVES FOR HIV TREATMENT
EA201692436A1 (en) MEDICAL APPLICATION
CL2016001918A1 (en) Heteroaryl amides as protein aggregation inhibitors
PH12019501639A1 (en) Jaki selective inhibitors
PH12017502376B1 (en) Oral solid formulation containing irinotecan and method of preparing the same
WO2014153495A9 (en) Novel stat3 inhibitors
EA201790432A1 (en) PROBES FOR VISUALIZATION PROTEIN HANTINGTIN
EA201890896A1 (en) SOLID PREPARATION FOR ORAL APPLICATION CONTAINING AMORPHOUS SOLIPHENACIN, AND A METHOD FOR ITS OBTAINING
CL2016002089A1 (en) Isoquinoline derivatives, their preparation procedure and the pharmaceutical compositions containing them
EA201790687A1 (en) QUINOLINCARBOXAMIDE FOR USE IN THE TREATMENT OF MULTIPLE MYELOMA
EA201692111A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES
IL276430A (en) Pharmaceutical compound, salts thereof, formulations thereof, and methods of making and using same
EA201591717A1 (en) Solid Forms of Vumurafenib Hydrochloride
EP3488845A4 (en) Formulation having improved ph-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof
EA201890412A1 (en) ANTIBACTERIAL AGENTS CONTAINING PIRAZINO [2,3-b] [1,4] OXAZIN-3-IT OR RELATED RING SYSTEM
EA201691741A1 (en) PHARMACEUTICAL COMPOSITION
EP3890750A4 (en) Carborane compounds, carborane analogs, and methods of use thereof
IL269884B1 (en) Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor
EP3560914A4 (en) Sulfonyl amidine as indoleamine-2,3-dioxygenase inhibitor, and preparation method therefor and use thereof
EA201800565A1 (en) COMPOSITION FOR THE TREATMENT OF EYE DISEASES CONTAINING (+) - AZASETRON
EA201501130A1 (en) OPHTHALMOLOGIC PHARMACEUTICAL COMPOSITION
EA202091403A1 (en) 2-OXO-1-PYRROLIDINYLIMIDAZOTHIAZOLE DERIVATIVES
PH12016502527B1 (en) Stabilized desmopressin